Iuliu Hatieganu University of Medicine and Pharmacy   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cluj Napoca Romania (1919)

Organization Overview

First Clinical Trial
2009
NCT02507635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Iuliu Hatieganu University of Medicine and Pharmacy | Iuliu Hatieganu University of medicine and pharmacy cluj-Napoca | "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca | Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca | UMF Iuliu Hatieganu Cluj-Napoca

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 1)

Delayed Emergence from Anesthesia (Phase 1)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Shock (Phase 2)

ST Elevation Myocardial Infarction (Phase 3)

Ventricular Remodeling (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 22